RECEIPT #SCOTT-
JAN 05, 2024
PREDICTION BY
Scott Galloway“If 2023 was the year of GPT-4, 2024 will be the year of GLP-1. That is, Ozempic, Mounjaro, and all GLP-1-related weight loss and diabetes treatment drugs.”
FOLLOW-UP
GLP-1 drugs did become a major economic and media narrative, with substantial market-cap gains for pharma and widespread discussion of their impact across various sectors, aligning with Galloway's prediction of it being the defining 'tech of the year' economically.
ORIGINAL SOURCE
No Mercy / No Malice